Invesaro

Stocks FICO Financial statements

Financial statements

FAIR ISAAC CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data FAIR ISAAC CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2019FY2021FY2022FY2023FY2024FY2025FY2026
Revenue9351,0321,1601,2951,3171,3771,5141,7181,9912,535
Cost of revenue288313337361332302311348354351
Gross profit6477208239339841,0751,2031,3691,6372,183
Research and development111128149166171147160172188209
Selling, general and administrative337377414421396384401463513681
Selling and marketing3.14.13.68.76.98.19.812.329.741.9
Operating income1821752542965055426437349251,266
Interest expense25.831.339.842.240.16995.5106134223
Other non-operating income-0.0912.92.283.217.75-2.146.341411.457.7
Pre-tax income1561572162574734715546428031,100
Income tax22.930.523.920.681.197.8124129151265
Net income133126192236392374429513652835
EBITDA2182062853265315636577479401,282
EPS, basic4.324.266.638.1313.6514.3417.1820.7826.9036.52
EPS, diluted4.144.066.347.9013.4014.1816.9320.4526.5436.32
Shares, basic (weighted)30.929.72929.128.7262524.724.222.9
Shares, diluted (weighted)32.231.230.329.929.326.325.425.124.623

Balance sheet

FY2017FY2018FY2019FY2019FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents10690106157195133137151134218
Receivables169267297334312322388427529603
Other current assets36.739.651.942.543.529.131.740.141.991.1
Total current assets311396456534551485556617705912
Property, plant and equipment40.748.85346.427.917.61138.567.797.1
Lease right-of-use assets57.747.336.725.729.626.226.4
Goodwill804801804812788761773783783792
Intangible assets21.214.514.19.244.12.020.920
Long-term investments13.818.120.225.531.924.53345.354.651.7
Other non-current assets5.6736.379.210595.6103116118113101
Total assets1,2561,3301,4331,6061,5681,4421,5751,7181,8682,075
Accounts payable19.520.323.12320.717.31922.532.334.7
Accrued liabilities32.13132.563.479.566.259.579.8115203
Deferred revenue55.4103111115105120137157187222
Short-term debt14223521895250305015400338
Total current liabilities327474491415559331368380849920
Long-term debt4635296077391,0091,8241,8122,1942,6564,922
Lease liabilities73.253.739.223.92219.218.8
Other non-current liabilities46.14856.849.76084.389.488.1
Total liabilities8291,0431,1441,2751,6792,2442,2632,6813,6145,948
Total debt4635296077391,0091,8241,8122,2093,0565,259
Paid-in capital1,1951,2111,2251,2191,2371,3001,3511,3671,3311,372
Retained earnings1,5981,7651,9572,1932,5852,9593,3883,9014,5535,388
Treasury stock-2,301-2,612-2,802-2,998-3,858-4,936-5,325-6,139-7,538-10,539
Other comprehensive income-66.5-76.4-90.1-83-75.9-125-102-91.6-92.1-94.5
Shareholders' equity466287290331-111-802-688-963-1,746-3,873
Total equity466287290331-111-802-688-963-1,746-3,873
Total liabilities and equity1,2561,3301,4331,6061,5681,4421,5751,7181,8682,075
Shares outstanding30.22928.929.127.625.224.824.423.821.4

Cash flow statement

FY2017FY2018FY2019FY2019FY2021FY2022FY2023FY2024FY2025FY2026
Net income133126192236392374429513652835
Depreciation and amortization36.230.231.630.425.620.514.613.81516.7
Stock-based compensation61.274.88393.7112115124149157185
Deferred income tax-6.2510.67.7-8.64-5.967.82-47.4-27.3-32.523.6
Change in receivables2.86-8.27-36.2-59.924.5-31.6-70.1-34.1-100-62.3
Change in payables-2.030.841.891.06-2.35-2.82.243.329.852.37
Cash from operations2262232603654245094696337791,072
Capital expenditures-19.8-31.3-24-22-7.57-6.03-4.24-8.88-8.92-2.14
Acquisitions00-15.900
Purchases of investments0-6.05-6.4-6.12-9.04-9.96-10.6-18.4-6.5-15.7
Sales and maturities of investments03.233.483.477.248.065.0315.92.1820.8
Cash from investing-20.6-14.1-42.8-24.6138-5.67-16-28-43.7-45.4
Debt issued040003500550001,5001,000
Debt repaid00-400
Stock issued14.51122.825.44.43.28.18.314.75.9
Share buybacks-188-343-229-235-874-1,104-406-822-1,415-3,046
Dividends paid-1.2400
Cash from financing-181-219-200-289-524-547-455-593-750-941
Exchange rate effect5.28-5.9-1.140.06-0.14-18.85.621.84-1.29-2.07
Net change in cash29.7-15.616.45138-62.23.5813.9-16.583.5
Free cash flow2061922363434165034656247701,070
Interest paid26.126.139.937.73857.296.9106104224
Income taxes paid31.313.418.810.271.565.3153134162226

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $715.15 on November 10, 2026.

Profitability

MetricValueHow it is calculated
Gross margin86.1%Gross profit / revenue.
Operating margin49.9%Operating income / revenue.
EBITDA margin50.6%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin43.4%Pre-tax income / revenue.
Net margin32.9%Net income / revenue.
FCF margin42.2%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin42.3%Cash from operations / revenue.
Effective tax rate24.1%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)42.4%Net income / average total assets.
Return on invested capital (ROIC)82.0%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue8.3%Research and development expense / revenue.
SG&A / revenue26.9%Selling, general and administrative expense / revenue.
Stock-based pay / revenue7.3%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.1%Capital expenditures / revenue.
D&A / revenue0.7%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y27.3%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y18.8%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y14.0%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y33.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y22.0%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y17.3%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y36.9%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y25.3%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y20.1%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y36.5%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y24.9%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y19.3%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y28.1%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y24.8%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y16.3%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y36.9%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y29.0%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y22.1%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y37.7%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y31.7%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y20.4%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y39.0%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y32.0%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y20.8%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y11.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y9.6%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y5.8%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-6.4%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-3.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-4.7%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.99xCurrent assets / current liabilities.
Quick ratio0.89x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.24x(Cash + short-term investments) / current liabilities.
Debt / assets253.4%Total debt / total assets.
Liabilities / assets286.7%Total liabilities / total assets.
Net debt$5.04BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA3.93xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage5.67xOperating income / interest expense.
Working capital-$8.0MCurrent assets - current liabilities.
Goodwill and intangibles / assets38.2%(Goodwill + intangible assets) / total assets.
Tangible book value-$4.67BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.29xRevenue / average total assets.
Fixed asset turnover30.8xRevenue / average property, plant and equipment.
Receivables turnover4.48xRevenue / average receivables.
Days sales outstanding82 days365 x average receivables / revenue.
Days payables35 days365 x average accounts payable / cost of revenue.
FCF conversion128.1%Free cash flow / net income, when net income is positive.
Capex / operating cash flow0.2%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$36.32Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$36.52Net income per basic share, as reported (split-adjusted).
Revenue per share$110.27Revenue / diluted weighted shares.
FCF per share$46.54Free cash flow / diluted weighted shares.
Operating cash flow per share$46.64Cash from operations / diluted weighted shares.
Book value per share-$181.15Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$218.19Tangible book value / shares outstanding.
Cash per share$10.18(Cash + short-term investments) / shares outstanding.
Buybacks / FCF284.7%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$15.45BShare price x shares outstanding.
Enterprise value$20.49BMarket cap + total debt - cash - short-term investments.
P/E18.5xMarket cap / net income. Only when net income is positive.
P/S6.09xMarket cap / revenue.
P/FCF14.4xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF14.4xMarket cap / cash from operations, when positive.
EV/Sales8.08xEnterprise value / revenue.
EV/EBIT16.2xEnterprise value / operating income, when both are positive.
EV/EBITDA16.0xEnterprise value / EBITDA, when both are positive.
EV/FCF19.1xEnterprise value / free cash flow, when both are positive.
FCF yield6.9%Free cash flow / market cap.
Earnings yield5.4%Net income / market cap (the inverse of P/E).
Shareholder yield19.7%(Dividends paid + share buybacks) / market cap.
PEG0.64xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was FAIR ISAAC CORP's revenue in fiscal 2026?

FAIR ISAAC CORP reported revenue of $2.53B for fiscal 2026, 27.3% higher than the year before.

Was FAIR ISAAC CORP profitable in fiscal 2026?

Yes. Net income was $835.0M, a net margin of 32.9%.

How much free cash flow did FAIR ISAAC CORP generate in fiscal 2026?

Cash from operations of $1.07B minus capital expenditures of $2.1M left free cash flow of $1.07B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to FAIR ISAAC CORP